Cargando…
Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
Toll-like receptor 9 (TLR9) is expressed in a variety of B-cell malignancies and works as a bridge between innate and adaptive immunity. CpG oligodeoxynucleotides (CpG ODNs), TLR9 agonists, are able to induce anticancer immune responses and exert direct effects against cancer cells, serving as cance...
Autores principales: | Bai, Ling, Chen, Wei, Chen, Jingtao, Li, Wei, Zhou, Lei, Niu, Chao, Han, Wei, Cui, Jiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329966/ https://www.ncbi.nlm.nih.gov/pubmed/28241765 http://dx.doi.org/10.1186/s12967-017-1152-5 |
Ejemplares similares
-
BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
por: Bai, Ling, et al.
Publicado: (2023) -
Toll-Like Receptors and Myocardial Inflammation
por: Feng, Yan, et al.
Publicado: (2011) -
Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014) -
Single Nucleotide Polymorphisms of Toll-Like Receptor 7 and Toll-Like Receptor 9 in Hepatitis C Virus Infection Patients from Central China
por: Wei, Xin-su, et al.
Publicado: (2014) -
The Role of Toll-Like Receptors in Hematopoietic Malignancies
por: Monlish, Darlene A., et al.
Publicado: (2016)